Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
von Willebrand disease and aging: an evolving phenotype.
Sanders YV, Giezenaar MA, Laros-van Gorkom BA, Meijer K, van der Bom JG, Cnossen MH, Nijziel MR, Ypma PF, Fijnvandraat K, Eikenboom J, Mauser-Bunschoten EP, Leebeek FW; WiN study group. Sanders YV, et al. Among authors: ypma pf. J Thromb Haemost. 2014 Jul;12(7):1066-75. doi: 10.1111/jth.12586. J Thromb Haemost. 2014. PMID: 24750783 Free article.
An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.
Mauser-Bunschoten EP, Kleine Budde I, Lopaciuk S, Koopman MM, Van Der Meer FJ, Novàkovà IR, Ypma P, Van Der Linden PW, Windyga J, Strengers PF. Mauser-Bunschoten EP, et al. Among authors: ypma p. Haemophilia. 2011 May;17(3):439-45. doi: 10.1111/j.1365-2516.2010.02453.x. Epub 2011 Mar 1. Haemophilia. 2011. PMID: 21362109 Clinical Trial.
Effect of fibrinolysis on bleeding phenotype in moderate and severe von Willebrand disease.
De Wee EM, Klaij K, Eikenboom HC, Van Der Bom JG, Fijnvandraat K, Laros-Van Gorkom BA, Mauser-Bunschoten EP, Meijer K, Goverde G, Van Der Linden PW, Rijken DC, Leebeek FW; WiN Study Group. De Wee EM, et al. Haemophilia. 2012 May;18(3):444-51. doi: 10.1111/j.1365-2516.2011.02645.x. Epub 2011 Sep 12. Haemophilia. 2012. PMID: 21910790
Gynaecological and obstetric bleeding in moderate and severe von Willebrand disease.
De Wee EM, Knol HM, Mauser-Bunschoten EP, van der Bom JG, Eikenboom JC, Fijnvandraat K, De Goede-Bolder A, Laros-van Gorkom B, Ypma PF, Zweegman S, Meijer K, Leebeek FW; WiN study group. De Wee EM, et al. Among authors: ypma pf. Thromb Haemost. 2011 Nov;106(5):885-92. doi: 10.1160/TH11-03-0180. Epub 2011 Sep 22. Thromb Haemost. 2011. PMID: 21947221
Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis.
Tuinenburg A, Rutten A, Kavousi M, Leebeek FW, Ypma PF, Laros-van Gorkom BA, Nijziel MR, Kamphuisen PW, Mauser-Bunschoten EP, Roosendaal G, Biesma DH, van der Lugt A, Hofman A, Witteman JC, Bots ML, Schutgens RE. Tuinenburg A, et al. Among authors: ypma pf. Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):799-804. doi: 10.1161/ATVBAHA.111.238162. Epub 2011 Dec 15. Arterioscler Thromb Vasc Biol. 2012. PMID: 22173226
Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor®): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety.
Hofstra JJ, Kleine Budde I, van Twuyver E, Choi G, Levi M, Leebeek FW, de Monchy JG, Ypma PF, Keizer RJ, Huitema AD, Strengers PF. Hofstra JJ, et al. Among authors: ypma pf. Clin Immunol. 2012 Mar;142(3):280-90. doi: 10.1016/j.clim.2011.11.005. Epub 2011 Nov 16. Clin Immunol. 2012. PMID: 22197071 Clinical Trial.
An observational, prospective, two-cohort comparison of a fixed versus variable dosing strategy of prothrombin complex concentrate to counteract vitamin K antagonists in 240 bleeding emergencies.
Khorsand N, Veeger NJ, van Hest RM, Ypma PF, Heidt J, Meijer K. Khorsand N, et al. Among authors: ypma pf. Haematologica. 2012 Oct;97(10):1501-6. doi: 10.3324/haematol.2012.063701. Epub 2012 Apr 4. Haematologica. 2012. PMID: 22491734 Free PMC article. Clinical Trial.
Reduced prevalence of arterial thrombosis in von Willebrand disease.
Sanders YV, Eikenboom J, de Wee EM, van der Bom JG, Cnossen MH, Degenaar-Dujardin ME, Fijnvandraat K, Kamphuisen PW, Laros-van Gorkom BA, Meijer K, Mauser-Bunschoten EP, Leebeek FW; WiN Study Group. Sanders YV, et al. J Thromb Haemost. 2013 May;11(5):845-54. doi: 10.1111/jth.12194. J Thromb Haemost. 2013. PMID: 23506463 Free article.
75 results